Cite
HARVARD Citation
Essink, B. et al. (2020). Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults. Vaccine. 38 (2), pp. 242-250. [Online].